Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-010719

EVP, Chief Legal Officer gave up 64,724 shares (to pay taxes)

  • EVP, Chief Legal Officer acquired 187,330 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Option exercise +22,645 22,645 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Shares withheld for taxes −6,943 $8.76 $60,821 15,702 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Option exercise +38,226 53,928 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Shares withheld for taxes −10,864 $8.76 $95,169 43,064 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Option exercise +90,580 133,644 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Shares withheld for taxes −31,338 $8.76 $274,521 102,306 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-04 Option exercise +35,879 138,185 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-04 Shares withheld for taxes −15,579 $8.84 $137,718 122,606 D
Derivatives
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Option exercise · Restricted Stock Units −22,645 22,645 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Option exercise · Restricted Stock Units −38,226 76,453 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Option exercise · Performance-Based Restricted Stock Units −90,580 0 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Grant or award · Performance-Based Restricted Stock Units +194,064 194,064 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-03 Grant or award · Restricted Stock Units +97,032 97,032 D
Daly Jason B. EVP, Chief Legal Officer 2025-03-04 Option exercise · Restricted Stock Units −35,879 107,640 D
Loading xslF345X05/wk-form4_1741224087.xml…